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ABSTRACT: A straightforward, two-step asymmetric syn-
thesis of octahydroindoles has been developed on the basis of
two complementary strategies: (i) an organocatalyzed Michael
reaction followed by a tandem Robinson−aza-Michael double
cyclization catalyzed by PS-BEMP, and (ii) a diastereoselective
cyclization, which formally constitutes a remote 1,6 asym-
metric induction mediated by PS-BEMP. This allowed the
construction of complex octahydroindoles with up to four
stereocenters, excellent enantioselectivities (up to 95% ee), and complete diastereoselective control in a single-pot operation.
DFT calculations were performed to understand the origin of this eﬀect.
■ INTRODUCTION
The organocatalyzed construction of highly functionalized
polycyclic nuclei in a one-pot operation from simple acyclic
precursors has the potential to greatly shorten a synthetic
sequence targeting complex natural products.1 Previously, we
have developed an organocatalytic strategy toward decahy-
droquinolines that allowed the synthesis of an advanced
common building block for a number of lycopodium alkaloids,
such as lycoposerramine Z2 and cermizine B.3 In both cases, the
tandem reaction was instrumental in enabling highly eﬃcient
syntheses of these natural products. Looking to expand the
potential of this methodology, it soon became apparent that the
principles4 behind the reaction sequence, namely a β-keto ester,
a tethered sulfonamide, and an enal engaging in a tandem
Robinson aza-Michael reaction (see Figure 1), could be more
general in scope, providing access to a range of diﬀerent
important nitrogen bicyclic nuclei in enantiopure form. Indeed,
this proved to be the case and allowed us to achieve the ﬁrst
eﬃcient synthetic entry to the morphan nucleus using
organocatalysis from simple acyclic precursors.5 Here, we
expand the scope of this strategy to include the octahy-
droindole unit,6 another privileged scaﬀold found in an
extensive and diverse range of compounds (Figure 2). These
include natural products such as aeruginosin 298-A,7 lycorine,8
daphniyunnine D,9 neotuberostemonine,10 pharmaceutical
products such as perindopril,11 and a number of proline
analogue organocatalysts.12
While a number of methods have been developed to
synthesize octahydroindoles in enantiopure form, using the
chiral pool approach13 or asymmetric metal-catalyzed reac-
tions,14 there are few previous approaches using amino-
catalysis.15
Detailed herein is the development of an organocatalysis-
mediated synthesis of octahydroindoles from a noncyclic
precursor. Notably, the process constitutes a rare example of
an intramolecular aza-Michael reaction through a 5-endo-trig
cyclization,16 the latter process being disfavored according to
Baldwin’s rules.17
■ RESULTS AND DISCUSSION
Preparation of the required starting material was achieved in a
one-step manner by ring opening of the commercially available
tosyl aziridines via the dianion of tert-butyl acetoacetate18 (eq
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Figure 1. Uniﬁed strategy to important nitrogen-containing nuclei
using an organocatalysis-initiated tandem Robinson aza-Michael
reaction.
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1). With the starting material 1a in hand, the nonasymmetric
version of the tandem cyclization reaction was initially
investigated. The key results are outlined in Table 1.
Satisfactorily, using the optimal conditions (crotonaldehyde
LiOH·H2O, i-PrOH, H2O) developed for the decahydroquino-
line series gave the desired analogous octahydroindole product
2a, which maintained the all-cis stereochemistry (Table 1, entry
1). The moderate yield led us to evaluate other conditions4
such as t-BuOK in t-BuOH19 (entry 2), which gave just 15% of
2a, with the rest (40%) recovered as the uncyclized
cyclohexenone. The use of n-Bu4NOH/KOH
20 gave similar
results, but it was found that if the reaction was lengthened to
72 h the desired product could be obtained in moderately good
yield (entry 3). We also evaluated the use of PS-BEMP with
Amberlyst-15 (B and C, Table 1) under the concept of site-
isolated reactivity using the conditions reported by Dixon.21
However, only traces of the Michael product were observed
(entry 4). Increasing the amount of PS-BEMP to 1 equiv gave a
good yield, but signiﬁcant quantities of the transesteriﬁcation
products were also isolated, presumably catalyzed by the acid
resin (entry 5). Switching the solvent to t-BuOH gave a slightly
less eﬃcient conversion, but with no transesteriﬁcation side
products (entry 6). However, using PS-BEMP alone in i-PrOH
gratifyingly gave 2a in moderate yield (entry 7), while
extending the reaction to 72 h gave the best yield so far of
68% (entry 8). Reducing the amount of PS-BEMP to catalytic
quantities was feasible, albeit at a cost of slightly reducing the
yield (entry 9). We also evaluated the more economical
Amberlyst-26 resin, but this did not perform so well, with the
yield dropping to 43% (entry 10).22
The relative stereochemistry of rac-2, which is the same for
all compounds synthesized in this series (see below), was
elucidated by 2D NMR spectra (COSY, HSQC, NOESY).
Octahydroindole 2a shows a preferred conformation in which
the C7−C7a bond of the carbocyclic ring adopts an axial
disposition with respect to the nitrogen-containing ring to
avoid the allylic strain with the sulfonamide group. The key
evidence for the structure depicted in Figure 3 was found in the
1H NMR coupling pattern for H-7ax, which appears as a triplet
of doublets (J = 12.8, 5.2 Hz). This coupling pattern is only
compatible with an axially disposed location of the methyl
group at C-6. Moreover, the axial proton H-7a is strongly
coupled with only one adjacent axial proton. Hence, its
resonance signal appears deceptively as a doublet (J = 12.8 Hz)
of other doublets (J = 8.0, 4.8 Hz). This structural elucidation is
fully conﬁrmed by the NOE contacts observed for H-7a (Figure
3).
In order to render the initial Michael addition step in the
tandem Robinson/aza-Michael reaction enantioselective, we
applied the conditions developed in the decahydroquinoline
series2 (using the Hayashi−Palomo catalyst 3,23 LiOAc as an
additive, and toluene as a solvent) to see if the octahydroindole
series followed the same reactivity pattern. A brief solvent
Figure 2. Diverse nitrogen-containing heterocycles with an embedded
octahydroindole ring.
Table 1. Screening of Tandem Cyclization Conditions
Leading to Octahydroindole 2a
entry base (equiv) solvent time (h) yielda (%)
1 LiOH·H2O (1)
b i-PrOH 24 44
2 t-BuOK (0.3) t-BuOH 24 15c
3 Ad (0.3), KOH (aq) Et2O/THF 72 57
4 Be (0.1), C (2) CH2Cl2 72
5 B (1), C (2) i-PrOH 24 56f
6 B (1), C (2) t-BuOH 24 45
7 B (1) i-PrOH 24 42
8 B (1) i-PrOH 72 68
9 B (0.1) i-PrOH 72 54
10 D (1) i-PrOH 24 43
aYield refers to the products isolated by ﬂash chromatography. b10
equiv of H2O added.
cSigniﬁcant amounts of the noncyclized
cyclohexenone were also obtained (∼40%). dTBAH refers to 40% n-
Bu4NOH in H2O.
ePS-BEMP refers to polymer-supported 2-(tert-
butylimino)-2-(diethylamino)-1,3-dimethylperhydro-1,3,2-diazaphos-
phorine. fIsolated as a mixture of esters by a solvent transesteriﬁcation
process.
Figure 3. Characteristic NMR data and selected NOEs of hydroindole
2a.
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screen for the organocatalytic step proved this to be the case, so
toluene was again selected as the solvent of choice based on ee
and yield. With the organocatalytic step suﬃciently optimized,
the use of diﬀerent cyclization conditions for the tandem
reaction were then evaluated. With no clear winner for the base
for the cyclization step, we decided to test all the conditions
that had given good results (see Table 1).
The use of LiOH gave 82% ee (Table 2, entry 1), which was
increased to 87% by lowering the reaction temperature (entry
5). We were surprised to observe that the choice of base was
indeed crucial for obtaining good enantioselectivities. Com-
pared to LiOH, the use of t-BuOK resulted in a quite
considerable reduction of the ee to 73% (entry 6), while the use
of KOH with TBAH under biphasic conditions gave an
improved ee of 94% (entry 7). The treatment with PS-BEMP
(1 equiv) performed almost equally well, giving 90% ee (entry
8). Using catalytic PS-BEMP conditions, the ee dropped
slightly to 87%, and the yield was signiﬁcantly reduced (entry
9). The use of the Amberlyst A26 resin resulted in a moderate
84% ee and also a moderate yield. While the KOH, TBAH
conditions (entry 7) were the best in terms of enantioselec-
tivity, we chose PS-BEMP (entry 8) as the optimum conditions
based on the following criteria: (i) the reaction setup and work
was signiﬁcantly easier, requiring simple addition and ﬁltration,
and (ii) we observed that KOH, TBAH was less eﬀective when
the enal substituent was not a methyl group. The absolute
conﬁguration proposed for octahydroindole (+)-2a is based on
the accepted mechanism of organocatalyzed Michael addition
of β-keto esters upon enals24 as well as the absolute
stereochemistry reported in the related process leading to
enantiopure decahydroquinolines.3
To test the scope of the reaction, a range of enals were
examined (Scheme 1). It should be noted that in cases where
the enal was not volatile, it was necessary to reduce any excess
material by hydrogenation before adding the base to initiate the
tandem cyclization reaction. Aliphatic enals gave the corre-
sponding octahydroindoles 2b and 2c with good enantiose-
lectivities (87% and 92% ee, respectively). The enal bearing a
free hydroxyl group eﬃciently gave 2d under racemic
conditions but did not evolve under organocatalysis due to
the formation of a stable heminal species. The reaction also
generally performed well when enals with a β-aromatic
substituent were used, giving 2e (phenyl group), 2f (p-
chlorophenyl) or 2g (p-methoxyphenyl), the latter bearing an
electron-donating substituent, and all with excellent enantiose-
lectivities.
Since many octahydroindole products bear a substituent at
the 2-position, we were interested in examining the eﬀect of
Table 2. Organocatalyzed Michael Reaction/Aldol/
Intramolecular Aza-Michael Process Leading to
Octahydroindole 2a
entry solvent
temp
(°C) cyclization conditionsa
yieldb
(%)
ee
(%)
1 toluene rt LiOH·H2O (T1
c: entry
1)
51 82
2 free rt T1: entry 1 7 14
3 MeOH rt T1: entry 1 40 77
4 CH2Cl2 rt T1: entry 1 27 85
5 toluene 0 LiOH·H2O, (T1: entry
1)
55 87
6 toluene 0 t-BuOK (T1: entry 2) 61 73
7 toluene 0 KOH, A, (T1: entry 3) 51 94
8 toluene 0 B (T1: entry 8) 50 90
9 toluene 0 B (T1: entry 9) 29 87
10 toluene 0 D (T1:entry 10) 44 84
aReactions were carried out with 1.1 equiv of crotonaldehyde and 0.5
equiv of LiOAc, as an additive, and the reaction time for the ﬁrst step
(i) was 24 h. The second step (ii) was carried out with the base
indicated in i-PrOH for 72 h. bYield refers to the products isolated by
ﬂash chromatography. cT1 refers to reaction conditions in Table 1.
Scheme 1. Scope of the Organocatalyzed Reactiona
aEach compound was prepared initially in racemic form using only the conditions of part iii of the transformation of 1a to 2b−g. bOrganocatalytic
conditions did not lead to any signiﬁcant quantity of coupled product. cExcess unreacted nonvolatile enal was converted by hydrogenation to the
corresponding aldehyde (see procedure C in the Experimental Section).
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placing a corresponding substituent in the β-keto ester starting
material α to the nitrogen (Table 3). We began by taking α-
substituted β-keto ester 1b and reacting it under the racemic
conditions (PS-BEMP, i-PrOH). Notably, the isolation of
compound 4a indicated that the incorporation of a stereogenic
center at the α-position of the nitrogen atom (i.e., a benzyl
group) caused an eﬀective remote 1,6-asymmetric induction.25
The stereostructure of 4a was assigned on the basis that the set
of signals in its NMR spectra (1H and 13C) showed a close
correlation with those observed in 2. Thus, considering that the
pattern of chemical shifts and coupling constants for H-3a, H-6,
H-7, and H-7a in 4a was the same as in 2a, a stereostructure
analogous to that depicted in Figure 1 but having the benzyl
substituent at C-2 was assigned to 4a with the all-cis
conﬁguration.
To see if the above asymmetric induction was an eﬀect
unique to PS-BEMP, the previously evaluated bases were
analyzed, and the product found in each case was 4a (Table 3).
The eﬀect of using the organocatalyst 3 in the initial Michael
step was then examined. While the matched organocatalyst
(−)-3 gave a similar result regarding the all-cis stereochemistry,
ent-3 failed to provide the opposite stereochemistry at C-6.
To explore the scope of the reaction, some diﬀerent
unsaturated aldehydes were used in the coupling reaction. As
can be seen in Table 3, the reaction worked with a variety of
substrates, leading to the octahydroindoles 4b−d in a
nonoptimized moderate yield.
Table 3. Scope of the Domino Process from Enantiopure
Acyclic β-Keto Ester 1b
entrya R compd conditions yield (%)
1 Me 4a PS-BEMP 44
2 Me 4a LiOH.H2O 60
3 Me 4a Amberlyst A-26 29
5 Me 4a BEMP 24
6 Me 4a 3b then PS-BEMP 27
7 Me 4a ent-3b then PS-BEMP c
8 Me 4a PS-BEMP (0.3) 45
9 Me 4a PS-BEMP (0.3)d 36
10 hept 4b PS-BEMP 28
11 (CH2)2OH 4c PS-BEMP 30
12 Ph 4d PS-BEMPe 43
aUnless otherwise stated, reactions were carried out with 1 equiv of
base in i-PrOH for 72 h. bConditions for the organocatalytic step were
carried out as in Table 2, entry 8. cA mixture of various unidentiﬁed
compounds was obtained with only traces of 4a. d10 equiv of H2O was
added. eThe use of LiOH·H2O gave signiﬁcantly lower yields when R
was > Me.
Figure 4. Proposed mechanism for the diastereoselective synthesis of enantiopure octahydroindoles 4: (a) Robinson annulation; (b) intramolecular
aza-Michael. Relative activation Gibbs Free energies computed at M062x/6-311+G** (CPCM = water) level of theory. Value in parentheses
corresponds to wB97xD/6-311+G** (water) single points.
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Next, we conducted DFT calculations26 in order to shed light
on the unexpected complete diastereoselectivity exerted by the
benzyl substituent on the bicycle formation. At ﬁrst sight, any
of the C−C or C−N bond-forming processes is a potential
candidate to be the stereodetermining transformation. We thus
considered all possibilities, starting with the initial Michael
addition of the dicarbonylic compound to cronotaldehyde
(TS1, see the SI), to form INT1-R and INT1-S (Figure 4),
which, as expected, turned out to be nonselective. The absence
of interaction between the forming C−C bond and the
stereogenic center α to the nitrogen atom might be behind the
observed lack of stereocontrol. The fact that TS1 is
nonselective undoubtedly means that INT1-R and INT1-S
must be in equilibrium (Curtin−Hammett conditions) prior to
the stereodetermining step, which we hypothesized to be TS2
(Figure 4a). A number of TS2 structures were located, showing
diﬀerent Li cation and H-bond (TsNH) activation modes of
the ring formation process. Gratifyingly, the transition state
lowest in energy (TS2-S1) corresponds to the formation of the
S epimer, which is the one experimentally observed. In this
structure (TS2-S1), the lithium atom is bonded to the two
reacting oxygen units (enolate and aldehyde) and the NH of
the tosyl group is hydrogen bonding the enolate oxygen. Any
other Li/NH bond combination (TS2-S2 to TS2-S4, Figure 4a)
is not so favorable in terms of energy. Similar activation modes
can be found in the transition states leading to the R epimer,
TS2-R1 being the lowest one, but their energies are at least
1.7−2.0 kcal/mol larger than those of the S isomer, in
agreement with the experimental selectivity data. We
hypothesized that the reason for the energy diﬀerence between
TS2-S1 and TS2-R1 might be the tight character of these
tricyclic structures, where the steric interaction of the benzyl
group with the rest of the molecule gains signiﬁcance.
We also studied the diastereoselectivity of the second ring
formation by attack of the nitrogen atom to INT2-S. The most
favorable transition states located were TS3-SR and TS3-SS
(Figure 4b), and the comparison of their relative Gibbs free
energies is again in agreement with the experimental results,
predicting the formation of the SS adduct. In both
diastereoisomers, the lithium cation is bonded to the oxygens
of the dicarbonylic system, activating the enone (INT2-S)
toward the nucleophilic attack of the tosylamine.
In conclusion, an eﬀective, enantioselective, organocatalytic
route to polyfunctionalized octahydroindoles was developed
using a one-pot sequence, further expanding the potential scope
of the organocatalyzed Robinson/aza-Michael reaction for the
rapid construction of important natural product nuclei. The
further application of this methodology to synthesize other
azabicyclic scaﬀolds and its use in total synthesis is currently in
progress in our laboratory. Moreover, a diastereoselective route
starting from commercially available enantiopure aziridine was
developed, in which a 1,6-remote control induction was
observed in a process leading to enantiopure 2,4,5,6-
tetrasubstituted hydroindoles.
■ EXPERIMENTAL SECTION
General Methods. All reactions were carried out under an argon
atmosphere with dry, freshly distilled solvents under anhydrous
conditions. Analytical thin-layer chromatography was performed on
SiO2 (silica gel 60 F254), and the spots were located with 1% aqueous
KMnO4. Chromatography refers to ﬂash chromatography and was
carried out on SiO2 (silica gel 60 ACC, 35−75 μm, 230−240 mesh).
Drying of organic extracts during workup of reactions was performed
over anhydrous Na2SO4. Chemical shifts of
1H and 13C NMR spectra
are reported in ppm downﬁeld (δ) from Me4Si. All NMR data
assignments are supported by gCOSY and gHSQC experiments. The
triphenylsilyl catalyst 3 was prepared by a literature procedure.23
tert-Butyl 6-(4-Methylphenylsulfonamido)-3-oxohexanoate
(1a).16 THF (40 mL) was added to NaH (60% in mineral oil)
(0.37 g, 9.22 mol), and the resulting suspension was cooled 0 °C. tert-
Butyl acetoacetate (0.73 g, 4.61 mmol) was added dropwise, and the
colorless solution was stirred at 0 °C for 10 min. Then n-butyllithium
(1.9 mL, 2.6 M in hexanes, 4.94 mmol) was added dropwise, and the
resulting orange solution was stirred at 0 °C for an additional 10 min.
N-Tosylaziridine (1.00 g, 5.07 mmol) in THF (5 mL) was added (the
color of the dianion faded on addition of the aziridine), and the
reaction mixture was stirred at room temperature for 15 min. The
mixture was quenched with aqueous NH4Cl (2 mL) plus 5 mL of
water (5 mL) and diluted with Et2O (15 mL). The organic phase was
washed with water, dried, and concentrated. Puriﬁcation by
chromatography (hexane to hexane/EtOAc 1:1) gave β-keto ester
1a (1.44 g, 88%) as a light colored oil: 1H NMR (CDCl3, 400 MHz) δ
1.44 (s, 9H, CH3), 1.75 (qd, J = 6.4, 0.8 Hz, 2H, CH2), 2.40 (s, 3H,
CH3), 2.54 (td, J = 6.8, 1.2 Hz, 2H, CH2), 2.92 (qd, J = 6.8, 1.2 Hz,
2H, CH2), 3.31 (s, 2H, CH2), 4.76 (br, 1H, NH), 7.28 (d, 2H, m-
ArH), 7.71 (d, 2H, o-ArH); 13C NMR (100 MHz, CDCl3) δ 21.4
(ArCH3), 23.1 (C-5), 27.8 (CH3), 39.4 (C-4), 42.2 (C-6), 50.4 (C-2),
82.1 (C), 127.1 (o-Ar), 129.7 (m-Ar), 136.9 (p-Ar), 143.3 (ipso-Ar),
166.6 (C-3), 202.9 (CO); HRMS (ESI-TOF) m/z [M + NH4]
+ calcd
for C17H29N2O5S 373.1792, found 373.1798.
tert-Butyl (S)-6-((4-Methylphenyl)sulfonamido)-3-oxo-7-phenyl-
heptanoate (1b). THF (10 mL) was added to NaH (60% mineral
oil, 113 mg, 2.84 mmol), and the resulting suspension was cooled to 0
°C. tert-Butyl acetoacetate (144 mg, 0.949 mmol) was added dropwise,
and the colorless solution was stirred at 0 °C for 10 min. Then n-
butyllithium (385 μL of 2.6 M in hexanes, 1.00 mmol) was added
dropwise, and the orange solution was stirred at 0 °C for an additional
10 min. (S)-(+)-2-Benzyl-1-(p-tolylsulfonyl)aziridine (1.04 mmol, 300
mg) in THF (1 mL) was added (the color of the dianion faded
immediately on addition of the aziridine), and the reaction mixture
was stirred at room temperature for 15 min. The mixture was
quenched with aqueous NH4Cl (1 mL) plus water (3 mL) and diluted
with Et2O (7 mL). The organic phase was washed with water, dried,
and concentrated. Puriﬁcation by chromatography (hexane to hexane/
EtOAc 1:1) gave β-keto ester 1b (334 mg, 79%) as a yellow oil: 1H
NMR (CDCl3, 400 MHz) δ 1.46 (s, 9H, CH3), 1.51−1.61 (m, 1H, H-
5), 1.78−1.86 (m, 1H, H-5), 2.41 (s, 3H, CH3), 2.52−2.65 (m, 4H,
2CH2), 3.29 (dd, J = 3.2 Hz, 2H, CH2), 3.40−3.49 (m, 1H, H-6), 4.63
(br, 1H, NH), 6.94 (dd, J = 7.6, 2.8 Hz, 2H, Ph), 7.17−7.20 (m, 3H,
Ph), 7.24 (d, J = 8.4 Hz, 2H, m-ArH), 7.64 (d, J = 8.4 Hz, 2H, o-ArH);
13C NMR (100 MHz, CDCl3) δ 21.5 (ArCH3), 27.9 (C-5), 28.0
(CH3), 38.9 (C-4), 41.8 (CH2), 50.5 (C-2), 54.3 (C-6), 81.9 (C),
126.7 (p-Ph), 126.9 (o-Ph), 128.5 (o-Ar), 129.3 (m-Ph), 129.7 (m-Ar),
136.6 (p-Ar), 137.7(p-Ph), 143.3 (ipso-Ar), 166.6 (C-3), 203.3 (CO);
HRMS (ESI-TOF) m/z [M + NH4]
+ calcd for C24H35N2O5S
463.2261, found 463.2254.
Representative Experimental Procedures for the Intermo-
lecular Michael/Aldol Cyclization/Intramolecular Aza-Michael
Reaction. General Procedure A. PS-BEMP (1.0 equiv) was added to
a solution of the β-keto ester (1.0 equiv) and Michael acceptor (1.1
equiv) in i-PrOH (4 mL/mmol), and the resulting mixture was stirred
at room temperature for 72 h. Filtration, evaporation of the solvent,
and chromatography gave the corresponding octahydroindole product.
General Procedure B. To β-keto ester (1.0 equiv) and Michael
acceptor (1.1 equiv) in toluene at 0 °C was added LiOAc (0.5 equiv)
followed by pyrrolidine 3 (0.1 equiv), and the resulting mixture was
stirred at 0 °C for 24 h. The solvent was removed in vacuo and the
residue dissolved in i-PrOH (4 mL/mmol). PS-BEMP (1.0 equiv) was
added, and the resulting mixture was stirred at room temperature for
72 h. Filtration, concentration, and chromatography gave the
corresponding enantioenriched octahydroindole product.
General Procedure C. To β-keto ester (1.0 equiv) and Michael
acceptor (1.1 equiv) in toluene at 0 °C was added LiOAc (0.5 equiv)
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followed by catalyst 3 (0.1 equiv), and the resulting mixture was stirred
at 0 °C for 24 h. The solvent was removed and the residue dissolved in
i-PrOH (4 mL/mmol). Pd/C (20% w/w) was added, and the ﬂask was
ﬁtted with a hydrogen balloon and hydrogenated until no enal was
observed. The mixture was ﬁltered through Celite, and the solvent was
evaporated in vacuo. PS-BEMP (1.0 equiv) was then added, and the
resulting mixture was stirred at room temperature for 72 h. Filtration
of the resin and chromatography gave the corresponding enantioen-
riched octahydroindole product.
rac-(3aR,6R,7aR)-tert-Butyl 4-Hydroxy-6-methyl-1-(4-methylphe-
nylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate (rac-
2a). Prepared according to general procedure A using crotonaldehyde
(26 μL, 0.309 mmol), β-keto ester 1a (100 mg, 0.281 mmol), PS-
BEMP (130 mg, 0.286 mmol), and i-PrOH (1 mL). Puriﬁcation by
chromatography (hexane to hexane/EtOAc 3:1) gave octahydroindole
rac-2a (78 mg, 68%) as a white solid: mp 131−132 °C; 1H NMR
(CDCl3, 400 MHz) δ 1.10 (s, 3H, CH3), 1.50 (s, 9H, CH3), 1.60 (td, J
= 12.8, 5.2 Hz, 1H, H-7ax), 1.90 (qd, J = 12.0, 8.0 Hz, 1H, H-3β), 2.02
(ddd, J = 13.0, 5.0, 2.4 Hz, 1H, H-7eq), 2.26 (dt, J = 12.0, 6.0 Hz, 1H,
H-3α), 2.35 (ddd, J = 12.0, 8.0, 7.2 Hz, 1H, H-3a), 2.44 (s, 3H,
ArCH3), 2.72 (qdd, J = 7.2, 2.8, 2.0 Hz, 1H, H-6eq), 3.06 (ddd, J =
12.0, 8.0, 6.0 Hz, 1H, H-2α), 3.58 (t, J = 8.0 Hz, 1H, H-2β), 3.93 (ddd,
J = 12.8, 8.0, 4.8 Hz, 1H, H-7a), 7.35 (d, 2H, m-ArH), 7.75 (d, 2H, o-
ArH); 13C NMR (100 MHz, CDCl3) δ 20.5 (CH3), 21.5 (ArCH3),
27.5 (C-6), 28.2 (CH3), 29.3 (C-3), 34.9 (C-7), 41.5 (C-3a), 47.9 (C-
2), 55.0 (C-7a) 81.5 (C), 104.2 (C-5), 127.4 (o-Ar), 129.8 (m-Ar),
134.4 (p-Ar), 143.5 (ipso-Ar), 169.0 (C-4), 171.9 (CO); HRMS (ESI-
TOF) m/z [M + H]+ calcd for C21H30NO5S 408.1839, found
408.1848.
(3aR,6R,7aR)-tert-Butyl 4-Hydroxy-6-methyl-1-(4-methylphenyl-
sulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate (2a).
Prepared according to general procedure B using β-keto ester 1a
(100 mg, 0.281 mmol), crotonaldehyde (22 mg, 0.309 mmol), catalyst
3 (14 mg, 0.028 mmol), LiOAc (9 mg, 0.141 mmol), and toluene (1.0
mL) at 0 °C for 24 h followed by cyclization with PS-BEMP (128 mg,
0.281 mmol) and i-PrOH (1 mL). Chromatography (hexane to
hexane/EtOAc 1:1) gave octahydroindole 2a (57 mg, 50%) as a white
solid: [α]D +110.9 (c 1, CHCl3). For analysis data, see the procedure
for rac-2a.
(3aR,6R,7aR)-tert-Butyl 4-Hydroxy-6-ethyl-1-(4-methylphenylsul-
fonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate (2b). Pre-
pared according to general procedure B using trans-pentanal (34 mg,
0.402 mmol), β-keto ester 1a (130 mg, 0.366 mmol), organocatalyst 3
(19 mg, 0.037 mmol), and LiOAc (12 mg, 0.183 mmol) in toluene
(1.4 mL) at 0 °C for 24 h followed by cyclization with PS-BEMP (166
mg, 0.366 mmol) and i-PrOH (1 mL). Chromatography (hexane to
hexane/EtOAc 3:1) gave octahydroindole 2b (78 mg, 51%) as a
yellow oil: 1H NMR (CDCl3, 400 MHz) δ 0.98 (t, J = 7.4 Hz, 3H,
CH3), 1.19−1.28 (m, 1H, H6-CH2), 1.38−1.44 (m, 1H, H-7), 1.49 (s,
9H, CH3), 1.50−1.57(m, 1H, H6-CH2) 1.89 (ddd, J = 19.6, 11.6, 7.6
Hz, 1H, H-3β), 2.20 (ddd, J = 4.7, 2.4 Hz, 1H, H-7eq), 2.21−2.29 (m,
1H, H-3α), 2.32−2.40 (m, 1H, H-6), 2.43 (s, 3H, ArCH3), 2.41−2.48
(m, 1H, H-3a), 3.05 (ddd, J = 11.6, 9.6, 6.4 Hz, 1H, H-2α), 3.58 (ddd,
J = 9.1, 7.8, 1.0 Hz, 1H, H-2β), 3.86 (ddd, J = 12.8, 8.2, 4.8 Hz, 1H, H-
7a), 7.32 (d, J = 7.9 Hz, 2H, m-ArH), 7.72 (d, J = 8.3 Hz, 2H, o-ArH);
13C NMR (100 MHz, CDCl3) δ 12.8 (CH3), 21.6 (ArCH3), 27.4
(CH2), 28.3 (CH3), 29.5 (C-3), 30.8 (C-7), 34.3 (C-6), 41.5 (C-3a),
48.0 (C-2), 55.1 (C-7a) 81.6 (C), 104.0 (C-5), 127.5 (o-Ar), 129.9 (m-
Ar), 134.4 (p-Ar), 143.6 (ipso-Ar), 169.4 (C-4), 172.1 (CO); HRMS
(ESI-TOF) m/z [M + H]+ calcd for C22H32NO5S 422.2005, found
422.1996.
(3aS,6S,7aS)-tert-Butyl 6-Heptyl-4-hydroxy-1-(4-methylphenyl-
sulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate (2c).
Prepared according to general procedure C using β-keto ester 1a
(100 mg, 0.281 mmol), trans-2-decenal (57 μL, 0.309 mmol), catalyst
3 (15 mg, 0.028 mmol), and LiOAc (9 mg, 0.140 mmol) in toluene (1
mL). Chromatography (hexane to hexane/EtOAc 1:1) gave
octahydroindole 2c (55 mg, 40%) as a white solid: mp 118−121
°C; 1H NMR (400 MHz, CDCl3) δ 0.91 (t, J = 6.8 Hz, 3H, CH3),
1.15−1.40 (m, 12H, H-alkyl), 1.41−1.50 (m, 1H, H-7), 1.50 (s, 9H,
CH3), 1.88 (dddd, J = 12.0, 12.0, 12.0, 8.0 Hz, 1H, H-3) 2.19 (ddd, J =
13.2, 4.4, 2.4 Hz, 1H, H-7), 2.27 (ddd, J = 12.4, 6.4, 6.4 Hz, 1H, H-3),
2.37 (dt, J = 12.0, 7.6 Hz, 1H, H-3a), 2.44 (s, 3H, ArCH3), 2.49−2.57
(m, 1H, H-6), 3.06 (ddd, J = 11.2, 9.6, 6.4 Hz, 1H, H-2), 3.58 (dd, J =
8.8, 8.8 Hz, 1H, H-2), 3.86 (ddd, J = 12.8, 8.4, 4.8 Hz, 1H, H-7a), 7.32
(d, J = 8.0 Hz, 2H, m-ArH), 7.71 (d, J = 8.4 Hz, 2H, o-ArH), 12.4 (s,
1H, enal); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3 side chain),
21.5 (ArCH3), 22.7 (CH2−alkyl), 27.8 (CH2−alkyl), 28.2 (CH3 t-Bu),
29.26 (CH2−alkyl), 29.33 (CH2−alkyl), 29.6 (C-3), 30.9 (C-7), 31.9
(CH2−alkyl), 32.3 (C-6), 34.2 (CH2−alkyl), 41.4 (C-3a), 47.9 (C-2),
54.9 (C-7a), 81.5 (C t-Bu), 104.0 (C-5), 127.4 (o-Ar), 129.7 (m-Ar),
134.3 (p-Ar), 143.5 (ipso-Ar), 169.2 (C-4), 172.0 (CO); HRMS (ESI-
TOF) m/z [M + H]+ calcd for C27H42NO5S 492.2778, found
492.2779.
(3aS,6R,7aS)-tert-Butyl 4-Hydroxy-6-(2-hydroxyethyl)-1-(4-meth-
ylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate
(rac-2d). Prepared according to general procedure A using (E)-5-
hydroxypent-2-enal27 (17 mg, 0.171 mmol), β-keto ester 1a (55 mg,
0.155 mmol), PS-BEMP (70 mg, 0.155 mmol), and i-PrOH (0.6 mL).
Chromatography (hexane to hexane/EtOAc 1:1) gave octahydroin-
dole rac-2d (42 mg, 61%) as a yellow oil: 1H NMR (400 MHz,
CDCl3) δ 1.52 (s, 9H, CH3), 1.53−1.62 (m, 2H, H-7 and H-1′), 1.71−
1.79 (m, 1H, H-1′) 1.90 (ddd, J = 12.0, 4.0 Hz, 1H, H-3), 2.19 (ddd, J
= 4.8, 2.4 Hz, 1H, H-7eq), 2.25−2.32 (m, 1H, H-3α), 2.37−2.42 (m,
1H, H-3a), 2.44 (s, 3H, ArCH3), 2.69−2.75 (m, 1H, H-6), 3.04 (ddd, J
= 11.2, 9.6, 6.4 Hz, 1H, H-2α), 3.58 (ddd, J = 9.2, 7.6, 0.8 Hz, 1H, H-
2β), 3.67−3.78 (m, 2H, H-2′), 3.93 (ddd, J = 13.2, 8.4, 4.8 Hz, 1H, H-
7a), 7.32 (d, J = 7.9 Hz, 2H, m-ArH), 7.72 (d, J = 8.3 Hz, 2H, o-ArH);
13C NMR (100 MHz, CDCl3) δ 21.7 (ArCH3), 28.4 (CH3), 29.4 (C-
3), 29.5 (C-6), 32.2 (C-7), 37.6 (C-1′), 41.6 (C-3a), 48.0 (C-2), 55.1
(C-7a), 61.4 (C-2′), 82.3 (C), 103.3 (C-5), 127.6 (o-Ar), 129.9 (m-
Ar), 134.3 (p-Ar), 143.8 (ipso-Ar), 170.1 (C-4), 171.9 (CO); HRMS
(ESI-TOF) m/z [M + H]+ calcd for C22H32NO6S 438.1949, found
438.1945.
(3aR,6R,7aR)-tert-Butyl 4-Hydroxy-1-(4-methylphenylsulfonyl)-6-
phenyl-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate (2e). Pre-
pared according to general procedure C using cinnamaldehyde (23
mg, 0.176 mmol), β-keto ester 1a (57 mg, 0.160 mmol), organo-
catalyst 3 (8 mg, 0.016 mmol), and LiOAc (5 mg, 0.080 mmol) in
toluene (0.5 mL). Chromatography (hexane to hexane/EtOAc 1:1)
gave octahydroindole 2e (36 mg, 41%) as a white solid: mp 168−170
°C; 1H NMR (400 MHz, CDCl3) δ 1.23 (s, 9H, CH3), 1.89−1.97 (m,
1H, H-7ax), 1.90−1.98 (m, 1H, H-3β), 2.17−2.20 (m, 1H, H-7eq),
2.90−2.26 (m, 1H, H-3α), 2.41−2.51 (m, 1H, H-3a), 2.41 (s, 3H,
ArCH3), 3.08 (td, J = 10.1, 6.6 Hz, 1H, H-2α), 3.54−3.58 (m, 1H, H-
7a), 3.58 (ddd, J = 12.0, 9.6, 7.6, 2.0 Hz, 1H, H-2β), 3.90 (t, J = 8.8 Hz,
1H, H-6eq), 7.07 (d, J = 7.2 Hz, 2H, m-Ph), 7.22 (d, J = 8.0 Hz, 2H, o-
Ph), 7.28 (d, J = 8.0 Hz, 2H, m-ArH), 7.60 (d, J = 8.4 Hz, 2H, o-ArH);
13C NMR (100 MHz, CDCl3) δ 21.5 (ArCH3), 27.8 (CH3), 28.8 (C-
3), 35.7 (C-7), 38.5 (C-6), 41.8 (C-3a), 48.2 (C-2), 54.7 (C-7a) 81.6
(C), 101.7 (C-5), 126.0 (o-Ph), 127.2 (m-Ph), 127.4 (o-Ar), 128.1 (p-
Ph) 129.6 (m-Ar), 133.7 (p-Ar), 143.4 (ipso-Ar), 144.1 (ipso-Ph),
170.7 (C-4), 171.7 (CO); HRMS (ESI-TOF) m/z [M + H]+ calcd for
C26H32NO5S 470.2001, found 470.1996.
(3aS,6R,7aS)-tert-Butyl 6-(4-Chlorophenyl)-4-hydroxy-1-(4-meth-
ylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carboxylate
(2f). Prepared according to general procedure C using 4-
chlorocinnamaldehyde (33 mg, 0.198 mmol), β-keto ester 1a (64
mg, 0.180 mmol), organocatalyst 3 (9 mg, 0.018 mmol), and LiOAc (6
mg, 0.090 mmol) in toluene (0.7 mL). Chromatography (hexane to
hexane/EtOAc 1:1) gave octahydroindole 2f (39 mg, 43%) as a white
solid: mp 185−187 °C; 1H NMR (400 MHz, CDCl3) δ 1.24 (s, 9H,
CH3), 1.89−2.00 (m, 2H, H-7ax, H-3β), 2.14 (dt, J = 7.6, 3.6 Hz, 1H,
H-7eq), 2.22 (dtd, J = 13.6, 8.8, 6.8 H, H-3α), 2.42 (s, 3H, ArCH3),
2.44−2.52 (m, 1H, H-3a), 3.08 (dt, J = 10.0, 6.4 Hz, 1H, H-2α), 3.47−
3.53 (m, 1H, H-6), 3.88 (t, J = 4.8 Hz, 1H, H-2β), 7.03 (d, J = 8.4 Hz,
2H, o-Ar), 7.25 (d, J = 8.8 Hz, 2H, m-Ar), 7.27 (d, J = 6.4 Hz, 2H, o-
Ph), 7.48 (d, J = 8.0 Hz, 2H, m-Ph); 13C NMR (100 MHz, CDCl3) δ
21.6 (ArCH3), 28.0 (CH3), 28.9 (C-3), 35.9 (C-7), 38.2 (C-6), 41.9
(C-3a), 48.3 (C-2), 54.7 (C-7a), 82.0 (C), 101.4 (C-5), 127.6 (o-Ar),
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128.4 (o-Ph), 128.7 (m-Ph), 129.8 (m-Ar), 131.9 (p-Ph), 133.8 (p-Ar),
143.0 (ipso-Ar), 143.8 (ipso-Ph), 170.9 (C-4), 171.6 (CO); HRMS
(ESI-TOF) m/z [M + H]+ calcd for C26H31ClNO5S 504.1606, found
504.1609.
(3aR,6R,7aR)-tert-Butyl 4-Hydroxy-6-(methoxyphenyl)-1-(4-
methylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-car-
boxylate (2g). Prepared according to general procedure C using trans-
4-methoxycinnamaldehyde (29 mg, 0.179 mmol), β-keto ester 1a (58
mg, 0.163 mmol), catalyst 3 (8 mg, 0.016 mmol), and LiOAc (5 mg,
0.082 mmol) in toluene (0.5 mL). Chromatography (hexane to
hexane/EtOAc 1:1) gave octahydroindole 2g (32 mg, 40%) as a white
solid: mp 152−154 °C; 1H NMR (400 MHz, CDCl3) δ 1.25 (s, 9H,
CH3), 1.87 (td, J = 12.8, 7.6 Hz, 1H, H-7ax), 1.90−2.00 (m, 1H, H-
3β), 2.16 (dt, J = 8.0, 4.0 Hz, 1H, H-7eq), 2.23 (ddd, J = 14.0, 8.4, 6.8
H, H-3α), 2.41 (s, 3H, ArCH3), 2.42−2.49 (m, 1H, H-3a), 3.07 (dt, J
= 10.0, 6.4 Hz, 1H, H-2α), 3.56−3.62 (m, 2H, H-6 and H-2β), 3.83 (s,
3H, CH3), 3.86 (dd, J = 5.2, 2.8 Hz, 1H, H-7a), 6.83 (d, J = 8.8 Hz,
2H, o-Ph), 6.99 (d, J = 8.8 Hz, 2H, o-Ar), 7.23 (d, J = 8.0 Hz, 2H, m-
Ar), 7.48 (d, J = 8.4 Hz, 2H, m-Ph); 13C NMR (100 MHz, CDCl3) δ
21.5 (ArCH3), 27.9 (CH3), 28.9 (C-3), 35.9 (C-7), 37.7 (C-6), 41.7
(C-3a), 48.2 (C-2), 54.7 (C-7a), 55.3 (OCH3), 81.6 (C), 101.8 (C-5),
113.5 (o-Ph), 127.4 (o-Ar), 128.1 (m-Ph), 129.6 (m-Ar), 133.7 (p-Ar),
136.2 (p-Ph), 143.4 (ipso-Ar), 157.8 (ipso-Ph), 170.3 (C-4), 171.7
(CO); HRMS (ESI-TOF) m/z [M + H]+ calcd for C27H34NO6S
500.2103, found 500.2101.
(2R,3aS,6S,7aS)-tert-Butyl 2-Benzyl-4-hydroxy-6-methyl-1-(4-
methylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-car-
boxylate (4a). Prepared according to general procedure A using β-
keto ester 1b (190 mg, 0.426 mmol), crotonaldehyde (36 mg, 0.511
mmol), PS-BEMP (194 mg, 0.426 mmol), and i-PrOH (2 mL).
Chromatography (hexane to hexane/EtOAc 1:1) gave octahydroin-
dole 4a (105 mg, 44%) as a colorless oil: [α]D −6.7 (c 1, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 1.07 (d, J = 7.2 Hz, 3H, CH3), 1.24−1.27
(m, 1H, H-7ax), 1.47 (s, 9H, CH3), 1.62−1.72 (m, 1H, H-3), 1.77
(ddd, J = 13.2, 4.8, 2.0 Hz, 1H, H-7eq) 1.98−2.04 (m, 1H, H-3a),
2.12−2.18 (m, 1H, H-3), 2.44 (s, 3H, ArCH3), 2.61 (qdd, J = 7.2, 5.6,
2.4 Hz, 1H, H-6), 2.94 (dd, J = 13.2, 8.8 Hz, 1H, CH2Ph), 3.40 (dd, J
= 13.2, 3.2 Hz, 1H, CH2Ph), 3.67−3.74 (m, 1H, H-2), 3.98 (ddd, J =
12.5, 7.8, 4.8 Hz, 1H, H-7a), 7.21−7.35 (m, 7H, ArH), 7.78 (d, J = 8.3
Hz, 2H, o-ArH); 13C NMR (100 MHz, CDCl3) δ 20.7 (CH3), 21.7
(ArCH3), 27.5 (C-6), 28.4 (CH3), 34.8 (C-7), 35.8 (C-3), 40.3 (C-
3a), 43.1 (CH2−Ph), 56.9 (C-7a), 62.2 (C-2), 81.7 (C), 104.0 (C-5),
126.7 (o-Ph), 127.6 (o-Ar), 128.4 (m-Ph), 130.0 (m-Ar), 130.1 (p-Ph),
134.6 (p-Ar), 137.7 (Ph), 143.9 (ipso-Ar), 169.3 (C-4), 172.1 (CO);
HRMS (ESI-TOF) m/z [M + H]+ calcd for C28H36NO5S 498.2309,
found 498.2293.
(2R,3aS,6S,7aS)-tert-Butyl 2-Benzyl-6-heptyl-4-hydroxy-1-(4-
methylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-5-car-
boxylate (4b). Prepared according to general procedure A using β-
keto ester 1b (100 mg, 0.224 mmol), trans-2-decenal (46 μL, 0.246
mmol), PS-BEMP (102 mg, 0.225 mmol), and i-PrOH (1 mL).
Chromatography (hexane to hexane/EtOAc 1:1) gave octahydroin-
dole 4b (36 mg, 28%) as a colorless oil: [α]D −12.7 (c 1, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 0.83−0.92 (m, 3H, CH3 alkyl), 1.10−1.18
(m, 1H, H-7), 1.18−1.38 (m, 12H, CH2 alkyl), 1.47 (s, 9H, CH3), 1.67
(ddd, J = 12.4, 12.4, 10.4 Hz, 1H, H-3), 1.93 (ddd, J = 13.2, 4.8, 2.4
Hz, 1H, H-7),2.04 (ddd, J = 12.4, 7.6, 7.2 Hz, 1H, H-3a), 2.16 (ddd, J
= 12.4, 7.2, 6.8 Hz, 1H, H-3), 2.38−2.46 (m, 1H, H-6), 2.44 (s, 3H,
ArCH3), 2.93 (dd, J = 13.2, 9.2 Hz, 1H, CH2Ph), 3.42 (dd, J = 13.2,
3.2 Hz, 1H, CH2Ph), 3.65−3.75 (m, 1H, H-2), 3.91 (ddd, J = 12.8, 8.0,
4.8 Hz, 1H, H-7a), 7.20−7.36 (m, 7H, ArH), 7.76 (d, J = 8.4 Hz, 2H,
m-Ar); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3 alkyl), 21.5
(ArCH3), 22.7 (CH2 alkyl) 27.8 (CH2 alkyl), 28.2 (CH3 t-Bu), 29.3
(CH2 alkyl), 29.6 (CH2 alkyl), 30.7 (C-7), 31.9 (CH2 alkyl), 32.2 (C-
6), 34.2 (CH2 alkyl), 35.8 (C-3), 40.0 (C-3a), 42.9 (CH2Ph), 56.8 (C-
7a), 62.0 (C-2), 81.5 (C t-Bu), 103.5 (C-5), 126.5, 127.5, 128.3, 129.8,
129.9, 134.5, 137.6, 143.7, 169.4 (C-4), 172.0 (CO); HRMS (ESI-
TOF) m/z [M + H]+ calcd for C34H48NO5S 582.3253, found
582.3262.
(2R,3aS,6R,7aS)-tert-Butyl 2-Benzyl-4-hydroxy-6-(2-hydroxyeth-
yl)-1-(4-methylphenylsulfonyl)-2,3,3a,6,7,7a-hexahydro-1H-indole-
5-carboxylate (4c). Prepared according to general procedure A using
β-keto ester 1b (56 mg, 0.126 mmol), (E)-5-hydroxypent-2-enal (14
mg, 0.138 mmol), PS-BEMP (57 mg, 0.126 mmol), and i-PrOH (0.5
mL). Puriﬁcation by chromatography (hexane to hexane/EtOAc 1:1)
gave octahydroindole 4c (20 mg, 30%) as a colorless oil: [α]D −17.1 (c
1, CHCl3);
1H NMR (400 MHz, CDCl3) δ 1.14−121 (m 1H, H-1′),
1.48−1.56 (m, 1H, H-3), 1.49 (s, 9H, CH3), 1.64−1.74 (m, 1H, H-3),
1.91−1.95 (dm, 1H, H-1′), 2.04−2.10 (m, 1H, H-3a), 2.14−2.20 (m,
1H, H-7), 2.44 (s, 3H, ArCH3), 2.60−2.62 (m, 1H, H-6), 2.95 (dd, J =
13.6, 8.8 Hz, 1H, CH2Ph), 3.40 (dd, J = 13.6, 3.2 Hz, 1H, CH2Ph),
3.61−3.75 (m, 3H, H-2, H-2′), 3.97 (ddd, J = 12.4, 7.2, 4.4 Hz, 1H, H-
7a), 7.21−7.35 (m, 5H, ArH), 7.35 (d, J = 8.0 Hz, 2H, o-Ar), 7.77 (d, J
= 8.0 Hz, 2H, m-Ar); 13C NMR (100 MHz, CDCl3) δ 21.7 (ArCH3),
28.4 (CH3), 29.3 (C-6), 31.9 (C-1′), 35.9 (C-7), 37.6 (C-3), 40.1 (C-
3a), 42.8 (CH2−Ph), 57.0 (C-7a), 61.4 (C-2′), 62.2 (C-2), 82.3 (C),
102.9 (C-5), 126.7, 127.6, 128.4, 130.1, 130.2, 134.4, 137.6, 144.0,
170.1 (C-4), 171.9 (CO); HRMS (ESI-TOF) m/z [M + H]+ calcd for
C29H38NO6S 528.2434, found 528.2414.
(2R,3aS,6R,7aS)-tert-Butyl 2-Benzyl-4-hydroxy-1-(4-methylphe-
nylsulfonyl)-6-phenyl-2,3,3a,6,7,7a-hexahydro-1H-indole-5-carbox-
ylate (4d). Prepared according to general procedure A using β-keto
ester 1b (49 mg, 0.110 mmol), cinnamaldehyde (16 mg, 0.121 mmol),
PS-BEMP (50 mg, 0.110 mmol), and i-PrOH (0.4 mL). Chromatog-
raphy (hexane to hexane/EtOAc 1:1) gave octahydroindole 4d (26
mg, 43%) as a white solid: mp 145−147 °C; [α]D −46.8 (c 1, CHCl3);
1H NMR (400 MHz, CDCl3) δ 1.19 (s, 9H, CH3), 1.49−1.55 (m, 1H,
H-3), 1.71−1.81 (m, 1H, H-7) 1.88 (dt, J = 13.2, 7.2, 3.2 Hz, 1H, H-
3), 2.11−2.20 (m, 2H, H-7, H-3a), 2.42 (s, 3H, ArCH3), 2.96 (dd, J =
13.2, 8.8 Hz, 1H, CH2Ph), 3.38 (dd, J = 13.2, 2.8 Hz, 1H, CH2Ph),
3.63 (ddd, J = 12.0, 7.6, 4.4 Hz, 1H, H-7a), 3.72−3.84 (m, 2H, H-2, H-
6), 7.01 (d, J = 7.6 Hz, 2H, o-Ar), 7.21−7.35 (m, 10H, ArH), 7.49 (d, J
= 8.0 Hz, 2H, m-Ar); 13C NMR (100 MHz, CDCl3) δ 21.7 (ArCH3),
28.0 (CH3), 34.9 (C-7), 35.5 (C-3), 38.8 (C-6), 40.4 (C-3a), 42.9
(CH2−Ph), 56.4 (C-7a), 62.5 (C-2), 81.7 (C), 101.2 (C-5), 126.2,
126.7 127.3, 127.6 128.2, 128.3, 128.6, 128.8, 129.8, 130.0, 130.2,
134.0, 137.7, 143.8, 144.2, 170.9 (C-4), 171.8 (CO); HRMS (ESI-
TOF) m/z [M + H]+ calcd for C33H38NO5S 560.2469, found
560.2465.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acs.joc.6b01568.
Analytical data and copies of HPLC and 1H and 13C
NMR spectra of the new compounds; Cartesian
coordinates and energies for all species considered in
Figure 4 (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: josep.bonjoch@ub.edu.
*E-mail: benbradshaw@ub.edu.
Author Contributions
§ISHC member.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
Financial support for this research was provided by the Projects
CTQ2013-41338-P and CTQ2013-47925_C2 from MINECO
(the Ministry of Economy and Competitiveness of Spain) and
the FP7 Marie Curie Actions of the European Commission via
the ITN ECHONET Network (MCITN-2012-316379). C.P. is
a recipient of a predoctoral fellowship (CONICYT, Chile). We
The Journal of Organic Chemistry Featured Article
DOI: 10.1021/acs.joc.6b01568
J. Org. Chem. XXXX, XXX, XXX−XXX
G
also thank IZO-SGI SGlker of UPV/EHU for their technical
and human support.
■ REFERENCES
(1) For reviews of organocatalysis in the synthesis of natural
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